SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM OF CANDESARTAN CILEXETIL WITH IMPROVED BIOAVAILABILITY

Abstract

Candesartan is an angiotensin II receptor blocker with inherent low bioavailability. The present studies entail the optimization and evaluation of self- nanoemulsifying drug delivery system (SNEDDS) of Candesartan in order to enhance its oral bioavailability. For this Capryol 90, Captex 500, Labrasol were used as oil, surfactant and co surfactant respectively. FTIR studies revealed no interaction among the drug and polymers used in the formulation. Based on the physicochemical parameters and in-vitro dissolution studies, F17 prepared with Smix (Surfactant: Co-surfactant) of 3:1 and Oil:Smix of 6:4, was found to be an optimum one. The formulation F17 was found to release 99.12 ± 5.10% drug at the end of one hour and scanning electron microscopic analysis showed nanosized particles. The droplet size of the optimized formulation was found to be 51.7 nm & Z-Average of 59.2 nm. The zeta potential of the optimized formulation (F17) was found to be -15.5 mV. The formulations were also found to be stable over a period of 6 months of testing. From in vivo bioavailability studies Cmax of the SNEDDS 35.2 ± 0.02 ng/ml was significant (p<0.05) as compared to the pure drug suspension formulation 25.1 ± 0.03ng/ml. Tmax of both SNEDDS formulation and pure drug suspension was 1.00 ± 0.03 h and 2.00 ± 0.01 h, respectively. AUC is an important parameter in evaluating bioavailability of drug from dosage form, AUC0-∞ infinity for SNEDDS formulation was higher (160.1±1.04ng. h/ml) than the pure drug suspension formulation 135.3 ± 2.02 ng.h/ml. Statistically, AUC0-t of the SNEDDS formulation was significantly higher (p<0.05) as compared to pure drug suspension formulation. Higher amount of drug concentration in blood indicated better systemic absorption of Candesartan from SNEDDS formulation as compared to the pure drug suspension formulation. The results from this study suggest the requirement for potential use of candesartan as self-nanoemulsifying drug delivery systems.

Authors and Affiliations

J. Venkateswara Rao, T. Rama Mohan Reddy

Keywords

Related Articles

IDENTIFICATION OF CYTOTOXIC AND ANTIOXIDANT COMPOUNDS FROM ALLIUM GRAMINEUM FLOWERS

The present study evaluates the in vitro anticancer, antiplasmodial and antioxidant activity of the ethanolic crude extract from the flowers of Allium gramineum growing in Georgia and of one flavonol and two steroidal gl...

FABRICATION AND CHARACTERIZATION OF CEFOPODOXIME PROXETIL SOLID DISPERSION FOR SOLUBILITY ENHANCEMENT

Cefopodoxime Proxetil belongs to BCS class IV and used in treatment of upper respiratory tract and urinary tract infections. Solid dispersions (SDs) are one of the most promising strategies to improve the solubility, dis...

ANTIMICROBIAL ACTIVITY OF WHOLE PLANT OF LUFFA CYLINDRICA (LINN) AGAINST SOME COMMON PATHOGENIC MICRO-ORGANISMS

In this present investigation was to evaluate the antimicrobial activity of pet ether and chloroform extract of whole plant of Luffa cylindrica (Linn) by in-vitro method in agar plate against ten bacterial and four funga...

PHARMACOGNOSTICAL AND PHYTOCHEMICAL INVESTIGATION ON LEAVES OF FICUS MICROCARPA LINN.

Ficus microcarpa Linn. (Syn: Ficus nitidas; Family: Moraceae) grows in Tropical and Subtropical regions of India, used for variety of purpose in traditional medicine. The usefulness of this plant is described in many fol...

A HIGHLY VALIDATED RP-HPLC METHOD DEVELOPMENT FOR THE SIMULTANEOUS ESTIMATION OF DAPAGLIFLOZIN AND SAXAGLIPTIN IN TABLET DOSAGE FORMS

A simple, accurate, precise method was developed for the simultaneous estimation of Dapagliflozin and Saxagliptin in Tablet dosage form. Chromatogram was run through Standard BDS C8 column (50 × 4.6 mm, 5m) The Mobile ph...

Download PDF file
  • EP ID EP622217
  • DOI 10.25004/IJPSDR.2018.100501
  • Views 71
  • Downloads 0

How To Cite

J. Venkateswara Rao, T. Rama Mohan Reddy (2018). SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM OF CANDESARTAN CILEXETIL WITH IMPROVED BIOAVAILABILITY. International Journal of Pharmaceutical Sciences and Drug Research, 10(5), 351-361. https://europub.co.uk/articles/-A-622217